Medtronic’s Endeavor Stent Hits Primary Endpoint In Pivotal Trial
This article was originally published in The Gray Sheet
Executive Summary
Medtronic's Endeavor zotarolimus-eluting stent is as effective as Boston Scientific's Taxus paclitaxel-eluting stent in the ENDEAVOR IV trial, Medtronic announced July 2